Introduction
Malaria and acquired immune deficiency syndrome (AIDS) are responsible for major health problems in many regions of the world. By the end of 2007, an estimated 33.2 million people were living with human immunodeficiency virus type-1 (HIV-1), of whom 2.5 million were newly infected (WHO, 2007) . Plasmodium falciparum, the infectious agent of malaria, is thought to be responsible for 1.5-2.7 million deaths and 350-500 million acute illnesses annually (Breman, 2001; WHO, 2002) . Together, both infectious diseases cause more than 4 million deaths a year. To a substantial extent P. falciparum and HIV-1 infections are concentrated in the same geographical regions. The resulting co-infection and interactions between the two pathogens have major public health implications. Studies based on P. falciparum and HIV-1 co-infection, whether clinical or laboratory, have been inconclusive to fully understand the exact mechanisms by which those two microorganisms interact.
HIV-1 is a single-stranded RNA retrovirus which can infect a number of different target cells, including CD4-expressing macrophages and T-helper lymphocytes. The infection begins with the interaction of the virus-encoded external glycoprotein 120 (i.e., gp120) with the host's cell surface CD4 molecule and chemokine coreceptor CCR5 or CXCR4. As the virus enters the cell, the conversion of the viral genomic RNA into double-stranded DNA is achieved by the virus-produced reverse transcriptase. Once reverse transcription has occurred, the pre-integration complex, promoted by HIV-1 DNA Flap formation, undergoes uncoating at the nuclear pore (Arhel et al., 2007) . Uncoating is an essential step in the viral replication cycle and the exact mechanism(s) involved remains controversial to this day. Thereafter, the viral DNA migrates to and enters the host cell nucleus and becomes integrated into the cell DNA with the help of the virus integrase. The provirus can then remain latent or be active, generating new virions emerging from the host cell membrane.
At the end of the 19th century, malaria was diagnosed by the presence of a dark pigment in various organs of patients (Hempelmann, 2007) . Later, Brown (1911) began a long and continuing debate by suggesting that those pigments were involved in various physiopathological aspects of malaria. The parasite multiplies by ingesting hemoglobin found in the host's cytosol. This process leads to hemoglobin degradation as a source of amino acids and the formation of free heme, which is a byproduct known to be highly toxic to the parasite. The essential first step in detoxification of heme is its incorporation into an intracellular crystal called malarial pigment or hemozoin (HZ) (Pisciotta and Sullivan, 2008) . Results from in vitro and in vivo studies indicate that, after the parasite's schizont rupture in red blood cells, crude HZ and a variety of attached components of parasite and host origin (e.g., lipids and phospholipids, lipid derivatives and proteins) are avidly taken up by phagocytes (i.e., Virology 395 (2009) [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] circulating neutrophils and monocytes and resident macrophages) (Arese and Schwarzer, 1997; Coban et al., 2002) . Interestingly, it has been demonstrated that HZ can persist in macrophages of infected individuals for several months (Millington et al., 2007; Pisciotta and Sullivan, 2008; Schwarzer et al., 1998) .
Blood-circulating monocytes when located in tissues can differentiate into macrophages and dendritic cells in response to danger stimuli (Mantovani, Sica, and Locati, 2005) . Due to their migratory behavior and their key functions in immune system responses, it is not surprising that cells of the monocyte-macrophage lineage are the preferential targets of both P. falciparum and HIV-1 (Arfi et al., 2008; McGilvray et al., 2000) . Like with P. falciparum, macrophages have been described as being important in HIV-1 infection by contributing to the pathogenesis of the disease throughout the course of infection (Kedzierska and Crowe, 2002) . Indeed, tissue macrophages can be infected with HIV-1 under both in vitro and in vivo conditions. Following infection with HIV-1, macrophages are resistant to the virus-mediated cytopathic effects and serve throughout the course of infection as long-term stable viral reservoirs capable of disseminating the virus to tissues.
Some of the diseases seen in the setting of P. falciparum and HIV-1 co-infection have been well described in a recent review paper (Skinner-Adams et al., 2008) . Although it is now appreciated that malaria and HIV-1 are causing bidirectional and synergistic interactions, there is still a paucity of data with regard to the mechanism(s) by which each pathogen impacts the other. Therefore, given the overlapping geographic distribution of both diseases and the urgent need for basic research in this area, the aims of this study were articulated as follows: (1) investigating whether exposure to the purified malaria pigment HZ influences HIV-1 replication in human primary macrophages and, if so, (2) understanding the mechanism(s) by which HZ can modulate the process of virus infection.
Results

Chemical synthesis and phagocytosis of malaria pigments
Synthetic HZ (sHZ), when prepared in vitro under acidic conditions, is spectroscopically identical and morphologically similar to the native HZ isolated directly from P. falciparum cultures (Taramelli et al., 2001) . Moreover, both synthetic and native HZ undergo the same process when internalized by phagocytes (Noland, Briones, and Sullivan, 2003; Olliaro et al., 2000; Pagola et al., 2000) . Consequently, most of our experiments were performed with synthetic HZ. The biological activity of our sHZ stock was authenticated by measurement of nitric oxide levels following a brief exposure of the murine macrophage cell line J774 to IFN-γ as described previously (Bergeron and Olivier, 2006; Jaramillo et al., 2003) . The sHZ preparation was found to be biologically active since a higher production of nitric oxide was seen in sHZ-treated cells upon the addition of IFN-γ (Fig. 1A) . Moreover, sHZ was found to mediate a significant secretion of IL-1β in human primary MDMs (Fig. 1B) , which confirms that the studied sHZ preparation is biologically active.
The next set of experiments was aimed at evaluating the ability of MDMs to engulf sHZ. To this end, cells were exposed to sHZ and phagocytosis of the malaria pigment was monitored during 24 h using a spinning disk confocal microscope. Acquisition was saved every 4 min and representative pictures were chosen. As shown in Fig. 2 , malaria pigments were phagocytosed efficiently by MDMs. Furthermore, a single cell can phagocyte several crystals of malaria pigments, but the number of phagosomes containing sHZ was restricted (i.e., a maximum of one to three per individual cell). Phagocytosis was not only observed during the chosen time-range but also during the entire recording (data not shown). For that reason, treatment of MDMs with sHZ was made 24 h prior to HIV-1 infection, unless otherwise specified.
sHZ inhibits HIV-1 replication in MDMs in a dose-dependent manner regardless of the viral preparations Next, we utilized sHZ to measure its putative impact on HIV-1 infection in MDMs. First, MDMs were initially treated for 24 h with increasing concentrations of sHZ (ranging from 0.1 to 25 μg/ml) and infected with fully infectious R5-tropic virus (i.e., NL4-3Balenv) for 16 days. Results illustrated in Fig. 3A indicate that HIV-1 production in MDMs is significantly reduced in a dose-dependent fashion by concentrations of sHZ starting at 5 μg/ml. Importantly, cell viability was not affected by doses of sHZ that can diminish virus replication as monitored by the fluorescent cytotoxic MTS assay (Fig. 3B ) and annexin V/7AA-D test (data not shown). To eliminate the possibility that sHZ could affect the phagocytic capability of MDMs, which could in turn reduce virus uptake, we estimated zymosan phagocytosis. As shown in Fig. 3C , sHZ is not altering the phagocytic capacity of MDMs.
Cells were then infected with four different R5-tropic virus preparations, i.e., fully infectious NL4-3Balenv and NL4-3Bal-HSA as well as single-cycle reporter virus pseudotyped either with JR-FL (NL4-3Luc
It should be noted that, unlike most of the previous reporter constructs, the NL4-3Bal-HSA molecular construct leads to the production of fully competent viruses with no deletions in env, vpr or nef. Moreover, NL4-3Bal-HSA virus codes for a cell surface reporter molecule, namely, the murine heat-stable antigen (HSA) CD24, which permits to quantify the percentage of cells productively infected with HIV-1 (Imbeault et al., 2009) . Virus infection was estimated at 6 days post-infection for all virus stocks tested by measuring either the p24 content, luciferase activity or percentage of HSA-expressing cells. ) were initially treated with PMA and next either left untreated (Ctrl) or treated with sHZ (10 μg/ml). Finally, half of the samples were incubated with IFN-γ (100 U/ml). Nitric oxide production was assessed through the use of the Griess reagent (A). Results are a schematic representation of data from triplicate samples ± SEM of three independent experiments. Human primary MDMs (5× 10 4 ) were either left untreated (Ctrl) or treated with sHZ (10 μg/ml) for the indicated time periods. Levels of IL-1β were assessed by using a commercial test (B). Measurements were done on two distinct donors.
Results from virus infection experiments confirmed that HIV-1 infection of MDMs with NL4-3Balenv was inhibited in a dosedependent fashion by sHZ (e.g., percentages of inhibition of 21 ± 4.1 at 0.1 μg/ml, 29 ± 5.2 at 1 μg/ml and 46 ± 4.6 at 10 μg/ml) (Fig. 4A) . Infection of MDMs in the absence of sHZ led to a virus production of 115 ± 24.5 ng/ml of p24. Infection with HIV-1 reporter virus pseudotyped with JR-FL envelope was also reduced in a dosedependent manner by sHZ (e.g., percentages of inhibition of 26 ± 2.7 at 0.1 μg/ml, 45 ± 5.8 at 1 μg/ml and 85 ± 7.1 at 10 μg/ml) (Fig. 4B) . Luciferase activity detected in untreated control cells was equal to 64 ± 11.1 relative light units (RLU). Similar observations were made when we used reporter virus that can enter target cells through endocytosis and independently of CD4 and chemokine coreceptor (i.e., NL4-3Luc (Fig. 4C) . However, as expected, reporter gene activity detected in untreated and treated MDMs was more important than when infection was performed with JR-FL pseudotypes (e.g., 2310 ± 1557 RLU in untreated control cells). Again, a significant sHZ-mediated reduction in virus production (about 43% at 25 μg/ml) was seen when MDMs were inoculated with fully competent HIV-1 particles that can express, in addition to all virus proteins, the murine cell surface molecule HSA (Fig. 4D) .
The physiological significance of our findings was addressed by comparing side-by-side our sHZ preparation with natural HZ directly isolated from P. falciparum cultures (PfHZ). Details of the procedure for the isolation of natural malaria pigments have already been described previously (Pisciotta et al., 2007) . As illustrated in Fig. 5 , infection of MDMs with JR-FL pseudotypes was inhibited at comparable significant levels in presence of sHZ and PfHZ (i.e., percentages of inhibition of 73 and 78, respectively).
sHZ-loaded MDMs are sensitive to HIV-1 infection
In view of the results shown above, we next wanted to define whether the sHZ-dependent diminution of HIV-1 gene expression is only occurring in cells loaded with malaria pigments. Accordingly, we performed confocal microscopy analyses using MDMs pretreated for 24 h with increasing concentrations of sHZ and then infected with fully competent HSA-encoding virus. Data from Fig. 6A demonstrated that the physical presence of sHZ in the target cell does not prevent HIV-1 infection and virus gene expression. Indeed, through the use of classical confocal microscopy (upper panels) and differential interference contrast microscopy (bottom panels), we were able to monitor at a single-cell level the frequency of sHZ-loaded MDMs and cells productively infected with HIV-1. Furthermore, at the highest concentrations tested (i.e., 10 and 25 μg/ml) more then 80% of the general population of MDMs accumulate sHZ in their cytoplasm. Although it is clear that a single cell can harbor sHZ and allow HIV-1 production, virus gene expression was rarely seen in MDMs filled with high quantities of sHZ. Indeed, an in-depth analysis of several hundred cells indicated that when an estimated 75% of the cell's cytoplasm was filled with sHZ those MDMs were weakly infected or not at all (see bottom panels and data not shown). Quantification of the image analysis corroborates that sHZ is abrogating virus production in MDMs (Fig. 6B ).
sHZ inhibits an early intracellular event in HIV-1 life cycle
In a previous work aimed at studying HIV-1 dynamics in cells isolated from HIV-1-infected patients, the duration of the virus replicative cycle in vivo was evaluated at 1.2 days on average (Perelson et al., 1996) . Moreover, the average HIV-1 generation time from release of a virion until it infects another cell and causes the release of a new generation of viral particles was estimated to be 2.6 days (Perelson et al., 1996) . Consequently, to identify which step(s) in the virus life cycle is affected by the malaria pigment, MDMs were infected with JR-FL pseudotypes and treated at different time points with two concentrations of sHZ. When 5 μg/ml of sHZ was added at 0 and 4 h post-infection, an important decrease in virus-encoded reporter gene activity was measured (i.e., percentages of inhibition of 48.2% and 38.9%, respectively) ( Fig. 7) . A similar diminution was seen when 10 μg/ml of sHZ was added at 0, 4 and 24 h post-infection (i.e., percentages of inhibition of 58.3, 45.8 and 38.7, respectively). Moreover, a more significant reduction in virus gene expression was detected when sHZ was added 24 h before HIV-1 infection (i.e., percentages of inhibition of 70.6 with 5 μg/ml and 79.4 with 10 μg/ ml). Importantly, the addition of sHZ at 48 and 72 h post-infection had no effect on HIV-1 expression, thus suggesting that malaria pigments are modulating an early event in the HIV-1 life cycle.
Next, we attempted to identify more precisely how sHZ can limit HIV-1 replication in MDMs. We evaluated whether ingestion of sHZ could reduce entry of virions within the studied target cells. To this end, MDMs were infected for 1 h either with fully infectious NL4-3Balenv or JR-FL pseudotypes, trypsinized and extensively washed to exposed to sHZ (10 μg/ml). Images were obtained using time lapse imaging, performed on a WAVE/FX spinning disk confocal microscope. Similar experimental conditions were maintained for all images throughout a 24 h recording (i.e., exposure time every 4 min, 60× magnification and laser and intensity levels). Representative images of sHZ phagocytosis by MDMs selected here illustrate the fluorescence imaging of stained cells (A) and the differential interference contrast images of the same cells (B). Digital images were processed with ImageJ (version1.36b) and Velocity (version 4.2.1, Improvision).
remove uninternalized viral entities. Finally, MDMs were lysed and p24 concentrations were quantified. No significant changes in virus internalization were noted when MDMs were treated with two different concentrations of sHZ before HIV-1 infection (Fig. 8 ).
Knowing malaria pigments had no impact on HIV-1 entry, we then monitored HIV-1 reverse transcription by quantifying various forms of virus reverse transcripts at different time points (i.e., 0, 4, 8, 24 and 48 h post-infection) in MDMs pretreated with 10 μg/ml of sHZ. Results obtained by real-time PCR assays indicate that the number of initiated and completed viral DNA copies is not reduced upon sHZ . sHZ inhibits HIV-1 replication in MDMs in a dose-dependent manner without affecting cell viability and phagocytic activity. MDMs were either left untreated (ctrl) or treated with increasing concentrations of sHZ (0.1-25 μg/ml) for 24 h. Next, cells were infected for 16 days with fully infectious virus (i.e., NL4-3Balenv) (A). The extent of virus infection was measured by estimating p24 contents every 3 days. At 16 days postinfection (dpi), cell viability was measured using MTS assay as described in Materials and methods (B). In some instances, MDMs were not infected and utilized as a positive control for cell viability (called mock). In some experiments, cells were pretreated with sHZ (10 μg/ml) and next incubated with fluorescently labeled zymosan to estimate the phagocytic potency of MDMs. Flow cytometry was used to define the percentage of zymosan-positive cells and mean fluorescence intensity (MFI). Results are a schematic representation of data from triplicate samples ± SEM of three independent experiments. Statistical analysis was performed on the results from all experiments. Asterisks denote statistically significant data (⁎⁎, P b 0.01).
treatment (data not shown and Fig. 9 ), therefore suggesting that the reverse transcription process is not a target of malaria pigments. Changes seen between samples in the copy numbers of HIV-1 reverse transcripts is most likely due to the intrinsic donor-to-donor variations. In such experiments, free heme was used as a positive control (data not shown) based on the previous demonstration that Fig. 5 . HIV-1 replication is similarly reduced by sHZ and PfHZ. MDMs were either left untreated (Ctrl) or treated with sHZ and PfHZ (10 μg/ml) for 24 h. Thereafter, cells were infected for 6 days with single-cycle HIV-1 reporter virus pseudotyped with JR-FL envelope. Finally, luciferase activity was measured using a luminometer and converted in percentages of inhibition as described in Fig. 3 . Statistical analysis was performed on the results. Asterisks denote statistically significant data (⁎⁎, P b 0.01). Fig. 6 . HIV-1 replication can occur in sHZ-loaded MDMs. Cells were either left untreated or treated with increasing concentrations of sHZ (1-25 μg/ml) for 24 h. Thereafter, cells were infected for 6 days with fully infectious reporter virus coding for cell surface murine HSA. Cells were mounted and processed for confocal microscopy analysis. MDMs were stained with Alexa Fluor 488-labelled phalloidin to reveal the F-actin cytoskeleton (red) and a conjugated antibody specific for HSA to reveal cells productively infected with HIV-1 (green) (A). . sHZ inhibits an early event in HIV-1 life cycle. MDMs were either left untreated or treated with the indicated concentrations of sHZ at different time points after (i.e., 0, 4, 24, 48 and 72 h) and 24 h before infection (PRE) for 6 days with single-cycle HIV-1 reporter virus pseudotyped with JR-FL envelope. Luciferase activity was measured using a luminometer. Virus infection is illustrated in percentages of inhibition as described in Fig. 3 . Results are mean ± SEM of data from triplicate samples of four independent experiments. Statistical analysis was performed on the results from all experiments. Asterisks denote statistically significant data (⁎, P b 0.05; ⁎⁎, P b 0.01).
this P. falciparum-mediated byproduct can inhibit HIV-1 reverse transcriptase activity (Staudinger et al., 1996) .
Thereafter, integrated viral DNA copies were estimated also by real-time PCR in MDMs pretreated with sHZ and infected with fully infectious HIV-1 particles (i.e., NL4-3Balenv). The integration process was significantly reduced by a pretreatment with sHZ (Fig. 10 ). Similar observations were made when using NL4-3Bal-HSA and JR-FL pseudotypes (data not shown).
Discussion
Little is known about the possible impact of malaria pigments on HIV-1 replication in human primary cells known to harbor the virus under natural conditions. Indeed, most studies are clinical and relate to HZ and its influence on mother-to-child transmission of HIV-1 (Chaisavaneeyakorn et al., 2003; Moore et al., 2004; Moormann et al., 1999) . We chose to focus our studies on malaria pigments because the presence of HZ in monocytes and neutrophils was described as a marker for disease severity (Huy et al., 2006) . Furthermore, pigmented neutrophils were associated with cerebral malaria and death in children with severe malaria (Lyke et al., 2003) . Several studies have shown significant functional impairments in human cells caused by the malaria pigment such as a defective generation of the oxidative burst, an impaired phagocytic competence and a reduced protein kinase C activity (Millington et al., 2007; Pisciotta and Sullivan, 2008; Schwarzer et al., 1998) . As a result, the more important HIV-1 load observed in some Plasmodium-infected individuals (Kublin et al., 2005) may be the result of the incapacity of the immune system to appropriately control other microbial infections possibly due to HZ-mediated disorders of innate immune cells. As so, we were interested in studying the impact of malaria pigments on the HIV-1 life cycle in human primary MDMs. Because the majority of studies aimed at deciphering the possible HZmodulated immune functional deficiencies were using transformed or immortalized cell lines, we firstly investigated whether co-infection results obtained with those cell lines were representative of data obtained with human primary cells such as MDMs. Preliminary studies showed an increase of HIV-1 infection in the human acute monocytic leukemia cell line, THP-1, upon a pretreatment with sHZ (data not Fig. 8 . Virus entry is not affected by sHZ. MDMs were either left untreated (Ctrl) or treated with sHZ (i.e., 5 and 10 μg/ml) for 24 h. Next, cells were incubated for 1 h at 37°C with fully competent NL4-3Balenv (A) and single-cycle HIV-1 reporter virus pseudotyped with JR-FL envelope (B). The virus-cell mixture was extensively washed and treated with trypsin (5 min at 37°C), washed again and finally lysed. The viral content was measured using the p24 assay. In some instances, MDMs were put in contact with HIV-1 for less than a minute (called Mock). Results are mean ± SEM of data from triplicate samples of five independent experiments. Statistical analysis was performed on the results from all experiments and no significant variations were measured. . sHZ is affecting viral integration in MDMs. MDMs were either left untreated (Ctrl) or treated with 5 μg/ml of sHZ for 24 h. Next, cells were infected for 48 h with fully competent NL4-3Balenv. Genomic DNA was extracted and quantification of integration events was achieved using a real-time PCR protocol described in Materials and methods.
Results are mean ± SEM of data from triplicate samples of six independent experiments. Asterisks denote statistically significant data (⁎⁎⁎, P b 0.001).
shown). Surprisingly, when similar studies were conducted with MDMs, sHZ was found to exert an opposite effect on HIV-1 replication. The explanation for this discrepancy is currently unknown and deserves to be more fully addressed.
Here we confirm that MDMs rapidly ingest large amounts of sHZ and demonstrate for the first time that the malaria pigment causes a reduction in HIV-1 replication in this cell type. It has been demonstrated that malaria pigment can induce a severe impairment of phagocytic cells functions. Therefore, we used a red-fluorescent dye to stain acidic compartments in live cells in order to appreciate interactions between sHZ and MDMs in an attempt to shed light on how sHZ can modulate virus replication. At a given point, fully functional cellular lysosomal compartments were interacting with sHZ-fed phagosomes but were incapable to induce their degradation (data not shown). Taking into account that last result and the possibility that the only presence of sHZ could preclude the uptake of HIV-1, we tested the ability of MDMs to phagocyte fluorescently labeled zymosan particles. No significant differences were noticed as compared to the untreated control cells.
The entry process is the first critical step in the HIV-1 replicative cycle. It has been reported that HIV-1 enters macrophages by macropinocytosis and viral receptor-mediated fusion (Maréchal et al., 2001; Yi et al., 2008) . Similar amounts of internalized virions were detected in both untreated and sHZ-loaded MDMs, therefore indicating that the reduction of viral infection observed in sHZ-loaded MDMs is not caused by a decrease in HIV-1 entry.
Following entry in the cytosol, incoming subviral complexes interact with the actin cytoskeleton and the microtubule network to reach the nuclear pore (Arhel et al., 2006a; Campbell, Nunez, and Hope, 2004; McDonald et al., 2002) . Any factor interfering with the actin and/or the microtubule network may affect the transit of the reverse transcription complex (RTC) to the nucleus and consequently the completion of the virus replicative cycle. The impact of sHZ engulfment on actin and microtubule networks remains unknown. However, based on data reported by Moller and colleagues (2002) who showed that uptake of indigestible particles induces cellular stiffness, impairs phagocytic activity and delays intracellular transport in macrophages, it can be proposed that sHZ can interfere with the integrity of the cytoskeletal network. Although we cannot exclude that the intracellular transport is affected by sHZ, data from experiments with zymosan revealed that sHZ does not affect phagocytosis. These results suggest that the cytoskeletal network remains functional in sHZ-loaded MDMs and can thus be used by HIV-1 to move toward the nucleus.
It is now accepted that reverse transcription (RT) is initiated within an integral capsid core during the transit toward the nucleus (Arhel et al., 2007) and completed at the nuclear pore. Interestingly, it has been established that agents affecting cytoskeleton crystallization alter as well the RT process and viral infection (Bukrinskaya et al., 1998) . Accordingly, we investigated whether the ability of HIV-1 to complete RT was affected in sHZ-loaded MDMs compared to untreated control cells. Results from a sensitive RT-PCR assay that can detect incomplete and complete reverse transcripts suggested that this step is not modulated by sHZ. However, when we quantified the level of the integrated proviral DNA copies, we found that sHZloaded MDMs contain less proviral DNA inserted within the host chromosome than in untreated control cells. Therefore, sHZ is most likely impairing a step taking place between completion of the RT process and integration of viral genome into the host DNA. Events occurring between these two different steps include the formation of viral DNA Flap (Arhel et al., 2006b; Hameau et al., 2001 ) and a threestranded DNA structure acting as a cis-determinant of the HIV-1 genome nuclear import, which promotes uncoating at the nuclear pore and rapid translocation within the nucleus (Arhel et al., 2007) . It is possible that the stress generated by the engulfment of sHZ renders MDMs more refractory to virus infection by promoting degradation of the RTC and/or disturbing processes such as uncoating and nuclear import. It is well recognized that some stressors exert a general control of the nuclear trafficking by affecting various components of the transport machinery (Kodiha et al., 2008a) . For example, heat shock and oxidative stress trigger nuclear accumulation of importin-α in the nuclei of growing cells (Kodiha et al., 2008a; Kodiha et al., 2008b; Miyamoto et al., 2004) . Interestingly, it has been demonstrated that the HIV-1 RTC is translocated in the nucleus through a mechanism relying on the viral protein Vpr and the cellular importin-α in human macrophages (Kamata et al., 2005; Nitahara-Kasahara et al., 2007; Vodicka et al., 1998) . Considering that ingestion of malaria pigments induces an oxidative stress in macrophages (Schwarzer et al., 1992; Taramelli et al., 2000) , we hypothesized that it could explain why a treatment of MDMs with sHZ leads to a decrease in HIV-1 integration. Indeed, it is possible that the sHZ-mediated induction of oxidative stress causes a nuclear import block by anchoring the importin-α in the nucleus, a phenomenon preventing translocation of the HIV-1 genome and its subsequent integration in the host DNA genome. On the other hand, preliminary results have revealed that sHZ-loaded MDMs contain less intracellular ATP than untreated control cells (data not shown). Knowing that translocation of the HIV-1 pre-integration complex to the nucleus is an active transport process which requires ATP (Bukrinsky et al., 1992; Bukrinsky et al., 1993) and that HIV-1 integrase was shown to bind ATP (Lipford, Worland, and Farnet, 1994) , it can be postulated that ingestion of malaria pigments could inhibit HIV-1 infection also via an ATPdependent pathway. Furthermore, nuclear accumulation of HIV-1 integrase does not result from passive diffusion but rather from an active transport that occurs through the nuclear pore complex (NPC) that may require ATP either to interact with the mediators of its import or for translocation (Depienne et al., 2001) . A more recent contradictory study also suggests that nuclear import of integrase appears to be dependent on the importin-α/β heterodimer rather than ATP (Hearps and Jans, 2006) . Thus the sHZ-mediated induction of oxidative stress could also impair nuclear import of integrase. Experiments are currently underway to address these scenarios.
Our observations that HIV-1 replication was reduced to the same extent when using similar concentrations of synthetic (i.e., sHZ) and native HZ (i.e., PfHZ) provide physiologic significance to this work. The clinical relevance of our results is further supported by the previous demonstration that, during infection, the amount of HZ following erythrocyte rupture can reach concentrations as high as 100 μg/ml (Sullivan et al., 1996) . Importantly, our findings were made using a maximal concentration of 25 μg/ml of sHZ.
Although data from the most recent clinical and epidemiological studies suggest that malaria and HIV-1 infections act synergistically to increase parasite and viral load, we demonstrate here that the malaria-derived HZ molecule displays a negative impact on HIV-1 replication in a cell type recognized as a major cellular reservoir for this retrovirus. It seems contradictory that a major constituent of P. falciparum would reduce virus gene expression when parasite proteins have been demonstrated to increase viral replication (Ayouba et al., 2008; Froebel et al., 2004) . Our data are also opposite to that of the Perkins group who found that heme crystals increased viral load in simian monocytes first stimulated with TNF-α (Nti et al., 2005) . The reason(s) for such a discrepancy probably stems from the fact that P. falciparum and HIV-1 interactions are multifaceted and complex. This is exemplified by our observations that HIV-1 replication in human primary CD4 + T cells is not affected by sHZ (data not shown). It can be proposed that HZ exerts a direct effect on the virus life cycle primarily in cells such as macrophages that can phagocyte the malaria pigment. However it cannot be totally excluded that HZ can exert a distinct and more indirect effect in other cell populations known to harbor HIV-1 by inducing secretion of soluble factors that can modulate virus gene expression. Additional studies are warranted to address this issue.
Conclusions
We demonstrate here that HIV-1 infection of human primary macrophages is significantly reduced by sHZ. This diminution is associated with a restriction at the level of integration of the HIV-1 genome within host chromosomes. Thus, it can be postulated that remnant HZ present in the reticuloendothelial cells in patients cured of malaria diseases or with chronic infection can diminish HIV-1 replication in tissue resident macrophages. Given that HIV-1 can reside within different cellular reservoirs, additional and more comprehensive basic studies are needed to fully understand the consequences of P. falciparum/HIV-1 interactions. This is vital for the discovery of promising drug combinations and the promotion of new prevention strategies to treat worldwide co-infected individuals.
Materials and methods
Antibodies
The anti-HIV-1 p24 hybridomas 31-90-25 and 183 H12-5C were obtained from the American Type Culture Collection (ATCC) (Manassas, VA) and the NIH AIDS Repository Reagent Program (Germantown, MD), respectively. Antibodies were purified by using MAbTrap protein affinity columns according to the manufacturer's instructions (Pharmacia Technology AB, Uppsala, Sweden). Alexa Fluor® 488 phalloidin (Molecular Probes, Eugene, OR) is a high-affinity probe for F-actin. The Vybrant® DiD cell-labeling solution (Molecular Probes) is a dye delivery solution that can be added directly to normal culture media to uniformly label suspended or attached cultured cells for use in cell-cell fusion, cellular adhesion and migration applications. The rat M1/69 monoclonal antibody reacts with the mouse CD24 molecule (BD Pharmingen, Mississauga, ON), also known as Heat Stable Antigen (HSA). This antibody was used in conjunction with Alexa Fluor® 555 goat anti-rat IgG (Molecular Probes).
Cells
Murine macrophage J774 cells and human embryonic kidney 293 T cells were obtained from the ATCC and cultured in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum. Peripheral blood mononuclear cells (PBMCs) from healthy donors were isolated by Ficoll-Hypaque gradient and plated in 75 cm 2 flasks (1 × 10 7 cells/ml) for 2 h in order to separate by plastic adherence monocytes from the other non-adherent cells. After several washes with endotoxin-free phosphate-buffered saline (PBS) (SigmaAldrich, Oakville, ON), monocytes were cultured in complete RPMI-1640 medium supplemented with 5% heat-inactivated autologous serum in the presence of M-CSF (100 ng/ml) for a minimum of 6 days. Finally, MDMs were recovered with a soft cell scraper following incubation with Accutase and plated in 48-well plates at a final concentration of 5 × 10 4 cells per well in complete RPMI-1640 medium supplemented with 5% autologous serum. Flow cytometry analyses revealed that the studied MDMs preparations were constituted mostly of CD14 + cells (i.e., ≥99%) and very few contaminating CD3 + T cells (i.e., about 0.1%) (data not shown).
Plasmids
The full-length R5-tropic infectious molecular clone of HIV-1 pNL4-3Balenv was generated by replacing the X4-tropic NL4-3 env gene with that of the Bal strain (kindly provided by R. Pomerantz, Thomas Jefferson University, Philadelphia, PA) (Dornadula et al., 1999) . The NL4-3Luc pseudotypes, respectively. The R5-tropic envelope-encoding JR-FLenv vector was kindly supplied by N. R. Landau (NYU School of Medicine, NY), whereas pHCMV-G was obtained from the AIDS Repository Reagent Program. The latter molecular construct codes for the broad host-range vesicular stomatitis virus envelope glycoprotein G (VSV-G) and is placed under the control of the human cytomegalovirus promoter. The pNLHSA-IRES molecular construct was obtained by replacing the eGFP gene in the NLENG1-IRES vector (NL4-3 backbone) (Levy et al., 2004) with the coding sequence for mouse HSA. Furthermore, the Bal envelope from the pNL4-3Balenv plasmid was inserted in the pNLHSA-IRES to produce the NL4-3Bal-HSA vector that can generate fully infectious R5-using virus coding for cell surface HSA as described recently (Imbeault et al., 2009) .
Synthetic HZ preparation
Production of synthetic HZ (sHZ) was achieved using a previously described methodology with slight modifications (Jaramillo et al., 2003) . Briefly, 90 mg of hemin chloride (Sigma-Aldrich) was solubilized in DMSO (crystallization solvent) and added to a 4 M acetate solution at pH 5.0. The suspension was stirred with a magnet for 6 h at 65°C. After adding a volume of 10% SDS, the suspension was centrifuged at 12,500 × g for 25 min. The pellet was then sonicated twice at the lowest setting in a solution made of 100 mM sodium bicarbonate [pH 9.0] and 0.5% SDS and centrifuged again. The pellet was then washed three times in SDS 2%, at least five times in sterile H 2 O and once in endotoxin-free PBS to eliminate residual SDS. The final pellet was resuspended in endotoxin-free PBS and aliquoted to obtain a solution of 652 μg/ml sHZ. Natural HZ directly isolated from P. falciparum cultures (PfHZ) was prepared using an established technique of serial washes in SDS, protease K digestion, 6 M urea washes and further SDS and water washes (Noland et al., 2003) . The total heme content of HZ was determined as described by Sullivan and co-workers (1996) . Parasite HZ or crystallized heme was incubated for 1 h in 2% SDS/20 mM NaOH to solubilize crystal into monomeric heme, which has a molar extinction coefficient of 1 × 10 5 at 400 nm.
Assessment of the biological activity of sHZ
Nitric oxide synthesis was measured by using the murine macrophage cell line J774. Briefly, cells were seeded in a 48-well plate (1.25 × 10 5 cells/well) and activated for 48 h with the functional analog of diacylglycerol 12-myristate 13-acetate (PMA) at 20 ng/ml. Cells were then either left untreated or treated with sHZ (10 μg/ml) for 24 h and washed with PBS. Next, nitric oxide production was induced in some samples by a treatment with interferon-γ (IFN-γ) (100 U/ml). After 48 h, samples were subjected to the Griess reagent (made of 1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride and 2.5% H 3 PO 4 ) to form a chromophore absorbing at 543 nm as described previously (Lorsbach et al., 1993; Stuehr and Marletta, 1985) . Secretion of IL-1β by MDMs was estimated by treating cells (5 × 10 4 ) with sHZ (10 μg/ml) for 1, 2 and 4 h. Later, triplicates of each conditions were pooled and a commercial enzymatic assay (R&D Systems) was used to measure IL-1β protein levels in undiluted supernatant of MDMs treated or not with sHZ. IL-1β measurements were done on two distinct donors according to the manufacturer's protocol.
Cell viability assay
MDMs (5 × 10 4 cells) were first treated with different concentrations of sHZ for 24 h and next incubated or not with NL4-3Balenv for 16 days at 37°C. Cells were then washed once with PBS and resuspended in fresh RPMI-1640 medium supplemented with 5% autologous serum where a MTS solution was added according to the manufacturer's protocol (ThermoFisher Scientific, catalogue number PRG5421). After 45 min at 37°C, absorbance of the formazan product was measured at 490 nm from the assay plate and was directly proportional to the number of living cells in culture.
Phagocytosis assay
MDMs (a minimum of 1 × 10 5 cells) were first either left untreated or treated with sHZ (10 μg/ml) for 24 h and next recovered with Accutase as described above. Thereafter, MDMs were resuspended in opaque FACS tubes in 1 ml of fresh RPMI-1640 medium supplemented with opsonized Alexa 488-labeled zymosan particles (Molecular Probes) in a ratio of 10:1 (zymosan:MDM). Cells were incubated for 0, 5, 15, 30 and 60 min at 37°C and kept on ice for the remaining of the experiment. Cells were washed and resuspended in endotoxin-free PBS. To quench non-incorporated zymosan particules, trypan blue pigments (Merck, Darmstadt, Germany) resuspended in a pH 4.4 citrate solution (0.4 mg/ml) were added and mixed to each sample before FACS analysis, representing 40% of the final concentration used. Finally, phagocytosis of zymosan particules in MDMs was analysed by flow cytometry (Epics ELITE ESP; Coulter Electronics).
Virus production
Viruses were produced by the calcium phosphate co-precipitation method in 293T cells as described previously (Fortin et al., 1997) . Briefly, 293T cells were transfected with pNL4-3Balenv or pNL4-3Bal-HSA to produce fully infectious R5-tropic HIV-1 particles. In addition, 293T cells were co-transfected with pNL4-3Luc + Env − R + and pJRFLenv or pHCMV-G to obtain pseudotyped HIV-1-based reporter virus. Virus preparations were normalized for virion content by using an inhouse enzymatic assay specific for the major viral p24 protein. In this test, 183 H12-5C and 31-90-25 are used in combination to quantify p24 levels (Bounou, Leclerc, and Tremblay, 2002) . Also, infectivity of our virus stocks was assessed through the use of TZM-bl indicator cells. This cell line is a genetically modified HeLa cell line expressing large amounts of cell surface CD4, CCR5 and CXCR4 (Steckbeck et al., 2005) . These cells carry separate integrated copies of the luciferase and β-galactosidase genes under the control of the HIV-1 promoter and are highly sensitive to infection with different HIV-1 variants (both R5-and X4-tropic). Virus preparations that did not allow sufficient reporter gene activity were discarded.
Measurements of HSA-expressing cells, luciferase activity and p24 content
Following infection of MDMs with NL4-3Bal-HSA virus, the percentage of HSA-expressing cells was estimated by flow cytometry. In brief, cells were stained either with an isotype-matched irrelevant control antibody (i.e., IgG1) or M1/69 followed by an Alexa Fluor® 555 goat anti-rat IgG, washed and fixed with paraformaldehyde. Further on, all cells were resuspended in a solution of PBS and measurements were made with a flow cytometer. Single stained cells were also used as controls for compensation adjustments. For MDMs infected with luciferase-encoding virus, reporter gene activity was monitored in cell lysates as previously described (Ouellet et al., 2003) . Replication of NL4-3Balenv virus was assessed by quantifying the accumulation of p24 protein in cell-free supernatant recovered from infected MDMs and loaded on an ELISA plate to perform our in-house sensitive double-antibody sandwich p24 test (Bounou, Leclerc, and Tremblay, 2002) .
Live cell microscopy
Images illustrated in Fig. 2 were obtained using time lapse imaging, performed on a WAVE/FX spinning disk confocal microscope (Quorum Technologies, Guelph, ON) equipped with a cell culture incubation chamber, a 60× glycerol objective and using the appropriate lasers and emission filters for fluorescent sources or white light for differential interference contrast. Images were processed using Volocity Software (Improvision, Waltham, MA). Briefly, MDMs were plated in eight chamber Lab-Tek™ slides (1 × 10 5 cells per well). Prior to cell culture incubation in the spinning disk, cells were treated with the DiD cell-labeling solution (1:500 dilution) and left in the chamber for 2 h to stabilized CO 2 and temperature levels. Later, sHZ (10 μg/ml) was added directly onto the cells. Recording was made during 24 h. Digital images were processed with ImageJ (version1.36b) and Velocity (version 4.2.1, Improvision). All the images were taken under similar experimental conditions (i.e., exposure time, 60× magnification and light and laser intensities).
Confocal microscopy
MDMs were seeded on coverslips, exposed to sHZ for 24 h and infected with NL4-3Bal-HSA virus for 7 days. The cells were then fixed with 2% paraformaldehyde and permeabilized using 0.1% Triton X-100. Nonspecific binding was blocked with 1% bovine serum albumin, 20% goat serum and 10% human serum in PBS. Cells were stained for actin cytoskeleton with Alexa Fluor 488® phalloidin and virusinfected cells were revealed with the rat anti-HSA monoclonal antibody used in combination with Alexa Fluor 555®-conjugated anti-rat IgG. After several washes, slides were mounted in SlowFade medium (Molecular Probes, Eugene, OR). Stained cells were visualized by confocal laser scanning microscopy (Fluoview FV300; Olympus, Melville, NY). Digital images were processed with Velocity (version 4.2.1, Improvision). All the images were taken under similar experimental conditions (i.e., exposure time, 60× magnification and light and laser intensities).
Kinetics of HIV-1 infection
MDMs were infected with a fixed amount of virus (i.e., 5 ng of p24 per 5 × 10 4 cells). In the case of infection with HIV-1 pseudotypes, viruses were left in the medium throughout the experiment while during infection with fully competent HIV-1 particles, half of the supernatant was collected and fresh medium was added every 3 days. In most studies, cells were treated with different concentrations of sHZ at 24 h before infection. Concerning the post-infection assay, MDMs were first infected with HIV-1 and then treated with sHZ at 0, 4, 24, 48 or 72 h post-infection.
Virus entry assay
MDMs (5 × 10 4 cells) were first treated with different concentrations of sHZ for 24 h and next incubated either with NL4-3Balenv or NL4-3Luc
/JR-FL pseudotypes (5 ng of p24) for 60 min at 37°C. Cells were then washed once with PBS, treated with trypsin for 5 min at 37°C to remove all uninternalized virions, washed three times and then immediately lysed in ice-cold lysis buffer (20 mM HEPES [pH 7.4], 150 mM sodium chloride and 0.5% Triton X 100). Finally, the p24 contents were evaluated by ELISA.
Real-time PCR
For detection and quantification of different forms of reverse transcripts (i.e., initiated and completed) and integrated viral DNA copies, genomic DNA from a total of 1 × 10 6 MDMs either left unexposed or treated for 24 h with Hz (10 μg/ml) and infected for up to 48 h with NL4-3Balenv was extracted using the DNeasy Blood and Tissue Kit from QIAGEN (Mississauga, ON). Quantification of HIV-1 reverse transcripts was achieved by subjecting 25 ng of DNA to a real-time PCR test in a 25 μl reaction containing 2× TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA), 1 μM of the HIV-1-specific sense primer M667, 1 μM of the HIV-1-specific antisense primer M661 and 0.3 μM of the TaqMan probe HIV-5′-carboxyfluorescein (Biosearch Technologies, Novato, CA) (Zack et al., 1990) . HIV-1 standards consisted of 25 ng of DNA from uninfected cells. For monitoring integrated viral DNA copies, DNA was quantified and subjected to a combined Alu-HIV-1 PCR and real-time PCR as described by Suzuki and co-workers (2003) . Briefly, genomic DNA (100 ng) from MDMs either left untreated or treated with sHZ (5 and 10 μg/ml) and infected for 48 h with HIV-1 was first amplified with an Alu-sequence-specific sense primer (Chun et al., 1997) and HIV-1-specific antisense primer (i.e., M661). Next, 5 μl of 25-fold diluted PCR products were subjected to a real-time PCR assay in a 25 μl reaction containing 2× TaqMan Universal PCR Master Mix (Applied Biosystems), 2 μM of the HIV-1-specific sense primer M667, 2 μM of the HIV-1-specific antisense primer AA55 and 0.3 μM of the TaqMan probe HIV-5′-carboxyfluorescein (Biosearch Technologies) (Suzuki et al., 2003) . The cycling conditions used for the Applied Biosystems 7500 sequence detection system included a hot start (50°C for 2 min and 95°C for 10 min), followed by 40 cycles of denaturation (95°C for 1 min) and extension (63°C for 1 min) with end point acquisition. NL4-3Balenv DNA was used for the standard curve (i.e., from 469 to 30,000 copies). All HIV-1 standards contained 1 ng of DNA from uninfected cells as carrier.
Statistical analysis
Results presented are expressed as means ± standard error of the mean (SEM) of triplicate samples. All of the experiments were repeated at least two times and each figure combines the results obtained with all the different donors. Because there might be some donor-to-donor variations, most figures are expressed as percentages of inhibition calculated with Prism version 3.03. Statistical significance between groups was determined by analysis of variance. Calculations were made with Prism version 3.03. P values b0.05 were considered statistically significant. The statistical significance of the results was defined by performing a one-way analysis of variance with Dunnett's post tests to compare treated and untreated control samples. In some cases, t test analyses were made on raw data.
